[Modification of the cardiovascular-dynamic effect of Akrinor following the blockade of adrenergic beta receptors with propranolol].
D002319:Cardiovascular System / Q000187:drug effects; D004338:Drug Combinations; D005021:Ethylamines / Q000494:pharmacology; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D011433:Propranolol / Q000494:pharmacology*; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects*; D013806:Theophylline / Q000031:analogs & derivatives* / Q000494:pharmacology
D004338:Drug Combinations; D005021:Ethylamines; D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; D011433:Propranolol; D013806:Theophylline
Die Beeinflussung der herz-kreislauf-dynamischen Wirkung von Akrinor nach Blockade der adrenergen Beta-Rezeptoren mit Propranolol.